l‐DOPA‐induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
In Parkinson's disease (PD),l‐DOPA therapy leads to the emergence of motor complications including l‐DOPA‐induced dyskinesia (LID). LID relies on a sequence of pre‐ and postsynaptic neuronal events, leading to abnormal corticostriatal neurotransmission and maladaptive changes in striatal projection neurons. In recent years, additional non‐neuronal mechanisms have been proposed to contribute to LID. Among these mechanisms, considerable attention has been focused on l‐DOPA‐induced inflammatory responses. Microglia and astrocytes are the main actors in neuroinflammatory responses, and their double role at the interface between immune and neurophysiological responses is starting to be elucidated. Both microglia and astrocytes express a multitude of neurotransmitter receptors and via the release of several soluble molecules modulate synaptic function in neuronal networks. Here we review preclinical and clinical evidence of glial overactivation by l‐DOPA, supporting a role of microglia and astrocytes in the development of LID. We propose that in PD, chronically and abnormally activated microglia and astrocytes lead to an aberrant neuron‐glia communication, which affect synaptic activity and neuroplasticity contributing to the development of LID.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720 · cited 2×
“Regrettably, long-term L-DOPA therapy results in the development of motor complications including motor fluctuations termed ‘on-off’, ‘wearing off’, and L-DOPA-induced dyskinesia (LID) (Jankovic, 2008).”
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196 · cited 2×
“Surrounding astrocytes convert glutamate to glutamine (using the enzyme glutamine synthase) and release glutamine into the interstitial space for uptake by neurons (Sofroniew & Vinters, 2010).”
BackgroundMethodThe Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · cited 3×
“In this situation, neuromelanin released by degenerating neurons activates microglia, giving rise to neuroinflammation (Zecca et al., 2008; Zlokovic, 2008).”
BackgroundCahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129 · cited 2×
“express further markers as vimentin, glutamine synthetase, brain lipid-binding protein, aldehyde dehydrogenase 1 family, member L1 (Aldh1l1; Cahoy et al., 2008; Barreto et al., 2011), and calcium-”
BackgroundMcGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045 · cited 1×
“It was demonstrated that a-synuclein, a pathological marker of PD, released from neuronal cells could be transferred to and accumulate in astrocytes and induce expression of genes associated with immune functions (Lee et al., 2010).”
BackgroundTripartite synapses: astrocytes process and control synaptic information
Perea, G., Navarrete, M., & Araque, A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.05.001 · Cited by 1,820 · cited 1×
“Astrocytes endfeets provide a contiguous sheath around capillaries forming the so called ‘neurovascular unit’, which undergo longlasting functional and structural adaptations in a number of neurological diseases (Simard et al., 2003; Zlokovic, 2008; Perea et al., 2009).”
BackgroundSynaptic scaling mediated by glial TNF-α
Stellwagen, D., & Malenka, R. C. (2006) · Nature · doi:10.1038/nature04671 · Cited by 1,715 · cited 2×
“Increased levels of TNF-a enhance synaptic strength at excitatory synapses via regulation of AMPA receptor trafficking and expression (Beattie et al., 2002; Stellwagen & Malenka, 2006).”
BackgroundMicroglial interactions with synapses are modulated by visual experience
Tremblay, M.-È., Lowery, R. L., & Majewska, A. K. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000527 · Cited by 1,542 · cited 4×
“…inputs to microglia have not been demonstrated to date, microglia can sense neuronal activity and modulate synaptic function of the healthy brain, by making physical contacts and interacting with presynaptic terminals, dendritic spines, and extrasynaptic neuronal parts (Tremblay et al., 2010).”
BackgroundInfluentialRascol, O., Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E., & Lang, A. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422004 · Cited by 1,539
Control of microglial neurotoxicity by the fractalkine receptor
Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531 · cited 5×
“As mentioned above, the CX3CR1/ CX3CL1 signaling holds a pivotal role in the neuron-microglia communication in the healthy brain.”
BackgroundInfluentialThe Mystery and Magic of Glia: A Perspective on Their Roles in Health and Disease
Barres, B. A. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.013 · Cited by 1,352 · cited 1×
“Finally, astrocytes tile the entire brain and serve vital trophic, active, and homeostatic roles (Barres, 2008).”
BackgroundControl of Synaptic Strength by Glial TNFα
Beattie, E. C., Stellwagen, D., Morishita, W., Bresnahan, J. C., Ha, B. K., Von Zastrow, M., Beattie, M. S., & Malenka, R. C. (2002) · Science · doi:10.1126/science.1067859 · Cited by 1,344 · cited 3×
“These modulate the activity of surrounding cells including other astrocytes, neurons, microglia, and the vasculature (Parpura et al., 1994; Schell et al., 1995; Cotrina et al., 1998; ; Beattie et al., 2002; Zonta et al., 2003).”
BackgroundNew roles for astrocytes: redefining the functional architecture of the brain.
Nedergaard, M., Ransom, B., & Goldman, S. A. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.08.008 · Cited by 1,334 · cited 4×
“mate uptake, which influences excitatory neurotransmission and prevents excitotoxicity (Tong & Jahr, 1994; Nedergaard et al., 2003; Holmseth, et al. 2009).”
BackgroundMethodInfluentialGliotransmitters Travel in Time and Space
Araque, A., Carmignoto, G., Haydon, P. G., Oliet, S. H. R., Robitaille, R., & Volterra, A. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.007 · Cited by 1,308 · cited 1×
“Astrocytes actively contribute to brain endocannabinoid signaling by secreting 2-AG (Blankman et al., 2009; Araque et al., 2014).”
BackgroundAstrocytic Purinergic Signaling Coordinates Synaptic Networks
Pascual, O., Casper, K. B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.-Y., Takano, H., Moss, S. J., McCarthy, K., & Haydon, P. G. (2005) · Science · doi:10.1126/science.1116916 · Cited by 1,280 · cited 2×
“The ATP release mechanisms still remain controversial; whether ATP potentiates or inhibits synaptic transmission is still under debate (for review see Pascual et al., 2005; Jenner, et al., 2009; Harada et al., 2016).”
BackgroundA Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
Blankman, J. L., Simon, G. M., & Cravatt, B. F. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.11.006 · Cited by 1,177 · cited 1×
“Astrocytes actively contribute to brain endocannabinoid signaling by secreting 2-AG (Blankman et al., 2009; Araque et al., 2014).”
BackgroundLiberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046 · cited 1×
“Astrocytes in the substantia nigra pars compacta of both PD patients (Hunot et al., 1996) and MPTP-treated mice (Dehmer et al., 2000; Liberatore et al., 1999), but not of controls, express high levels of iNOS.”
BackgroundTansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045
Systemic infections and inflammation affect chronic neurodegeneration
Perry, V. H., Cunningham, C., & Holmes, C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2015 · Cited by 1,027
Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90746-3 · Cited by 986
Differential Regulation of AMPA Receptor and GABA Receptor Trafficking by Tumor Necrosis Factor-α
Stellwagen, D., Beattie, E. C., Seo, J. Y., & Malenka, R. C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4486-04.2005 · Cited by 985 · cited 1×
“Among cytokines, TNF-a neuroregulatory function, in addition to its role in inflammatory responses, has been clearly demonstrated (Stellwagen et al., 2005).”
BackgroundLee, H.-J., Suk, J.-E., Patrick, C., Bae, E.-J., Cho, J.-H., Rho, S., Hwang, D., Masliah, E., & Lee, S.-J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081125 · Cited by 877 · cited 2×
“It was demonstrated that a-synuclein, a pathological marker of PD, released from neuronal cells could be transferred to and accumulate in astrocytes and induce expression of genes associated with immune functions (Lee et al., 2010).”
BackgroundMogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90508-8 · Cited by 855 · cited 1×
“…in the SN, putamen, as well as in the cerebrospinal fluid (CSF) and serum of PD patients suggest that microglia may acquire a prevalent pro-inflammatory phenotype in the disease (Mogi et al., 1994a,b, 2007; Blum-Degen et al., 1995; Hunot et al., 1999; Knott et al., 2000; Imamura et al., 2003).”
BackgroundSchell, M. J., Molliver, M. E., & Snyder, S. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3948 · Cited by 832 · cited 2×
“D-Serine (d-Ser) is an endogenous co-agonist of the glutamate NMDA receptor (Schell et al., 1995).”
BackgroundLoss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia
Picconi, B., Centonze, D., Håkansson, K., Bernardi, G., Greengard, P., Fisone, G., Cenci, M. A., & Calabresi, P. (2003) · Nature Neuroscience · doi:10.1038/nn1040 · Cited by 821 · cited 1×
“…are highly expressed on the SPNs that innervate directly the efferent nuclei of the basal ganglia (Gerfen et al., 1990), and their abnormal activation results in a strong stimulation of the cyclic adenosine monophosphate (cAMP) signaling pathway (Picconi et al., 2003; Santini et al., 2007).”
BackgroundSelf-citationThe myeloid cells of the central nervous system parenchyma
Ransohoff, R. M., & Cardona, A. E. (2010) · Nature · doi:10.1038/nature09615 · Cited by 804 · cited 2×
“These include receptors such as CD-200R, CD45, TREM2, CD172a, which are bound to the cognate neuronal receptor, respectively CD200, CD22, HSP60, CD47, through a cell–cell interaction (Hoek et al., 2000; Barclay et al., 2002; Ransohoff & Cardona, 2010).”
BackgroundUDP acting at P2Y6 receptors is a mediator of microglial phagocytosis
Koizumi, S., Shigemoto-Mogami, Y., Nasu-Tada, K., Shinozaki, Y., Ohsawa, K., Tsuda, M., Joshi, B. V., Jacobson, K. A., Kohsaka, S., & Inoue, K. (2007) · Nature · doi:10.1038/nature05704 · Cited by 802
Blum-Degena, D., Müller, T., Kuhn, W., Gerlach, M., Przuntek, H., & Riederer, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12192-7 · Cited by 801
Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0766-2 · Cited by 791 · cited 2×
“…in the SN, putamen, as well as in the cerebrospinal fluid (CSF) and serum of PD patients suggest that microglia may acquire a prevalent pro-inflammatory phenotype in the disease (Mogi et al., 1994a,b, 2007; Blum-Degen et al., 1995; Hunot et al., 1999; Knott et al., 2000; Imamura et al., 2003).”
BackgroundSulforhodamine 101 as a specific marker of astroglia in the neocortex in vivo
Nimmerjahn, A., Kirchhoff, F., Kerr, J. N. D., & Helmchen, F. (2004) · Nature Methods · doi:10.1038/nmeth706 · Cited by 784
Takeuchi, H., Jin, S., Wang, J., Zhang, G., Kawanokuchi, J., Kuno, R., Sonobe, Y., Mizuno, T., & Suzumura, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600504200 · Cited by 749 · cited 1×
“Many of these receptors are sensitive to microglial secretions acting in an autocrine manner, likely providing a fast feedback for immediate microglia adaptation to threatening signals (Takeuchi et al., 2006).”
BackgroundOlanow, C. W., Kieburtz, K., Odin, P., Espay, A. J., Standaert, D. G., Fernandez, H. H., Vanagunas, A., Othman, A. A., Widnell, K. L., Robieson, W. Z., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70293-x · Cited by 716 · cited 1×
“Accordingly, it is well known that continuous intrajejunal L-DOPA infusion, which provides a stable striatal DA tone, is associated with a low dyskinetic potential as compared to standard oral L-DOPA (Olanow et al., 2014).”
BackgroundGlial reactions in Parkinson's disease
McGeer, P. L., & McGeer, E. G. (2008) · Movement Disorders · doi:10.1002/mds.21751 · Cited by 701 · cited 2×
“Nevertheless, astroglial contribution to pathogenesis of PD has never been studied in great detail, and existing data are rather fragmentary (McGeer & McGeer, 2008; Verkhratsky et al., 2016a,b).”
BackgroundInteractions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659
CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity
Rogers, J. T., Morganti, J. M., Bachstetter, A. D., Hudson, C. E., Peters, M. M., Grimmig, B. A., Weeber, E. J., Bickford, P. C., & Gemma, C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3667-11.2011 · Cited by 624 · cited 1×
“These mice showed hippocampal microgliosis associated with increased levels of pro-inflammatory cytokines and impaired motor learning and cognitive function (Rogers et al., 2011).”
BackgroundNitric oxide synthase and neuronal vulnerability in parkinson's disease
Hunot, S., Boissière, F., Faucheux, B., Brugg, B., Mouatt-Prigent, A., Agid, Y., & Hirsch, E. C. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00578-1 · Cited by 595
Signaling at the Gliovascular Interface
Simard, M., Arcuino, G., Takano, T., Liu, Q. S., & Nedergaard, M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-27-09254.2003 · Cited by 586 · cited 2×
“Importantly, microvessels are positioned along the interfaces between adjacent astrocytic domains, being surrounded by astrocytes endfeets, which provide a contiguous but non-overlapping sheath around the capillary (Simard et al., 2003).”
BackgroundGlial cells in (patho)physiology
Parpura, V., Heneka, M. T., Montana, V., Oliet, S. H. R., Schousboe, A., Haydon, P. G., Stout, R. F., Spray, D. C., Reichenbach, A., Pannicke, T., et al. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07664.x · Cited by 561 · cited 2×
“ment proteins GFAP, vimentin, nestin, and synemin (Sofroniew & Vinters, 2010; Parpura et al., 2012; Hol & Pekny, 2015).”
BackgroundContribution of astrocytes to hippocampal long-term potentiation through release of d -serine
Yang, Y., Ge, W., Chen, Y., Zhang, Z., Shen, W., Wu, C., Poo, M., & Duan, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2431073100 · Cited by 533
Inflammatory Regulators in Parkinson's Disease: iNOS, Lipocortin-1, and Cyclooxygenases-1 and -2
Knott, C., Stern, G., & Wilkin, G. P. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0914 · Cited by 503 · cited 1×
“…in the SN, putamen, as well as in the cerebrospinal fluid (CSF) and serum of PD patients suggest that microglia may acquire a prevalent pro-inflammatory phenotype in the disease (Mogi et al., 1994a,b, 2007; Blum-Degen et al., 1995; Hunot et al., 1999; Knott et al., 2000; Imamura et al., 2003).”
BackgroundBraak, H., Sastre, M., & Del Tredici, K. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0244-3 · Cited by 462 · cited 1×
“Braak et al. (2007) reported an increased number of dystrophic astrocytes suggesting an increased glial activation in PD patients.”
BackgroundElusive roles for reactive astrocytes in neurodegenerative diseases
Ben Haim, L., Carrillo-de Sauvage, M.-A., Ceyzériat, K., & Escartin, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00278 · Cited by 453
Croisier, E., Moran, L. B., Dexter, D. T., Pearce, R. K., & Graeber, M. B. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-14 · Cited by 414
Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion
Verkhratsky, A., Matteoli, M., Parpura, V., Mothet, J., & Zorec, R. (2016) · The EMBO Journal · doi:10.15252/embj.201592705 · Cited by 397 · cited 3×
“Nevertheless, astroglial contribution to pathogenesis of PD has never been studied in great detail, and existing data are rather fragmentary (McGeer & McGeer, 2008; Verkhratsky et al., 2016a,b).”
BackgroundThe P2X 7 Receptor Drives Microglial Activation and Proliferation: A Trophic Role for P2X 7 R Pore
Monif, M., Reid, C. A., Powell, K. L., Smart, M. L., & Williams, D. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5512-08.2009 · Cited by 374 · cited 1×
“Similarly, P2X7 receptors drive microglial activation and proliferation (Monif et al., 2009).”
BackgroundSpencer, J. P. E., Jenner, P., Daniel, S. E., Lees, A. J., Marsden, D. C., & Halliwell, B. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052112.x · Cited by 373 · cited 2×
“In the early 1990s, a number of in vitro studies suggested that high doses of L-DOPA can be toxic to dopaminergic neurons in cell culture (Spencer et al., 1998).”
BackgroundTaylor, D. L., Jones, F., Kubota, E. S. F. C. S., & Pocock, J. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4456-04.2005 · Cited by 308
Microglial phenotypes in Parkinson’s disease and animal models of the disease
Joers, V., Tansey, M. G., Mulas, G., & Carta, A. R. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.006 · Cited by 285
Self-citationIntraneuronal dopamine-quinone synthesis: a review
Sulzer, D., & Zecca, L. (1999) · Neurotoxicity Research · doi:10.1007/bf03033289 · Cited by 284
Roles of glutamine in neurotransmission
Albrecht, J., Sidoryk-Węgrzynowicz, M., Zielińska, M., & Aschner, M. (2010) · Neuron Glia Biology · doi:10.1017/s1740925x11000093 · Cited by 273
Iannaccone, S., Cerami, C., Alessio, M., Garibotto, V., Panzacchi, A., Olivieri, S., Gelsomino, G., Moresco, R. M., & Perani, D. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.07.002 · Cited by 221 · cited 2×
“Imaging studies confirmed the presence of microgliosis in the brain of live PD patients, already at early disease stages (Iannaccone et al., 2013; Gerhard, 2016).”
BackgroundMori, K., Ozaki, E., Zhang, B., Yang, L., Yokoyama, A., Takeda, I., Maeda, N., Sakanaka, M., & Tanaka, J. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00211-3 · Cited by 215
Bridges, R., Lutgen, V., Lobner, D., & Baker, D. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.003889 · Cited by 205 · cited 3×
“glutamate, as described in astrocytes (Piani & Fontana, 1994; Bridges et al., 2012).”
BackgroundSelective activation of microglia facilitates synaptic strength
Clark, A. K., Gruber-Schoffnegger, D., Drdla-Schutting, R., Gerhold, K. J., Malcangio, M., & Sandkühler, J. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2061-14.2015 · Cited by 171 · cited 3×
“A recent study suggested that selective activation of microglia is sufficient to enhance synaptic strength (Clark et al., 2015).”
BackgroundMethodInfluentialCrowley, T., Cryan, J. F., Downer, E. J., & O’Leary, O. F. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.02.001 · Cited by 150
Increased CSF biomarkers of angiogenesis in Parkinson disease
Janelidze, S., Lindqvist, D., Francardo, V., Hall, S., Zetterberg, H., Blennow, K., Adler, C. H., Beach, T. G., Serrano, G. E., van Westen, D., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002151 · Cited by 150
Koeglsperger, T., Li, S., Brenneis, C., Saulnier, J. L., Mayo, L., Carrier, Y., Selkoe, D. J., & Weiner, H. L. (2013) · Glia · doi:10.1002/glia.22490 · Cited by 73 · cited 2×
“resulted in aberrant synaptic plasticity in the hippocampus (Koeglsperger et al., 2013).”
Background
Cited by
Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease
Zhang, Q.-S., Heng, Y., Mou, Z., Huang, J.-Y., Yuan, Y.-H., & Chen, N.-H. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.49 · Cited by 208
The Link between Gut Dysbiosis and Neuroinflammation in Parkinson’s Disease
Baizabal-Carvallo, J. F., & Alonso-Juarez, M. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.02.030 · Cited by 130
Palasz, E., Niewiadomski, W., Gasiorowska, A., Wysocka, A., Stepniewska, A., & Niewiadomska, G. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01143 · Cited by 95
“Elevated levels of interleukin-6 (IL-6) acting as proinflammatory cytokine, tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), and nitric oxide synthase (NOS), found in the SN, putamen, as well as in the cerebrospinal fluid (CSF) and serum of PD patients suggest that, in PD, glial cells acquire a pro-inf…”
BackgroundBortolanza, M., do Nascimento, G. C., Raisman‐Vozari, R., & Del‐Bel, E. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15439 · Cited by 33
Metadata
- Authors
- Carta, A. R., Mulas, G., Bortolanza, M., Duarte, T., Pillai, E., Fisone, G., Vozari, R. R., & Del‐Bel, E.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2016-12-09
- Volume
- 45
- Issue
- 1
- Pages
- 73-91
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2549997522
- Cited by
- 75
- References
- 60
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.